CHANELLE PHARMACEUTICALS MANUFACTURING LTD 156455 (Q233918): Difference between revisions

@@ Property / Irish Koesio Identifier @@
@@ Property / Irish Koesio Identifier: 514 / rank @@
-Normal rank
@@ Property / instance of @@
-Kohesio project
@@ Property / instance of: Kohesio project / rank @@
-Normal rank
@@ Property / financed by @@
-European Union
@@ Property / financed by: European Union / rank @@
-Normal rank
@@ Property / financed by @@
-Directorate-General for Regional and Urban Policy
-Normal rank
@@ Property / country @@
-Ireland
@@ Property / country: Ireland / rank @@
-Normal rank
@@ Property / EU contribution @@
-,556.475 EuroAmount 50,556.475 Euro
Unit Euro
-Amount
+,556.475 Euro
-Unit
+Euro
@@ Property / EU contribution: 50,556.475 Euro / rank @@
-Normal rank
@@ Property / budget @@
-,112.95 EuroAmount 101,112.95 Euro
Unit Euro
-Amount
+,112.95 Euro
-Unit
+Euro
@@ Property / budget: 101,112.95 Euro / rank @@
-Normal rank
@@ Property / coordinate location @@
-°16'27.88"N, 9°2'56.62"WLatitude 53.2744122
Longitude -9.0490632
Precision 1.0E-5
Globe http://www.wikidata.org/entity/Q2
-Latitude
+.2744122
-Longitude
+-9.0490632
-Precision
+.0E-5
-Globe
+http://www.wikidata.org/entity/Q2
@@ Property / coordinate location: 53°16'27.88"N, 9°2'56.62"W / rank @@
-Normal rank
@@ Property / start time @@
-April 2014Timestamp +2014-04-04T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2014-04-04T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / start time: 4 April 2014 / rank @@
-Normal rank
@@ Property / end time @@
-September 2017Timestamp +2017-09-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2017-09-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / end time: 15 September 2017 / rank @@
-Normal rank
@@ Property / co-financing rate @@
-.0 percentAmount 50.0 percent
Unit percent
-Amount
+.0 percent
-Unit
+percent
@@ Property / co-financing rate: 50.0 percent / rank @@
-Normal rank
@@ Property / beneficiary name (string) @@
-CHANELLE PHARMACEUTICALS MANUFACTURING LTD
-Normal rank
@@ Property / summary @@
-Develop a range of medical products (English)
@@ Property / summary: Develop a range of medical products (English) / rank @@
-Normal rank

Revision as of 09:17, 25 March 2020

Project in Ireland financed by DG Regio

Language	Label	Description	Also known as
English	CHANELLE PHARMACEUTICALS MANUFACTURING LTD 156455	Project in Ireland financed by DG Regio

Statements

programme

Border Midland and Western Regional - ERDF

0 references

CHANELLE PHARMACEUTICALS MANUFACTURING LTD 156455 (Q233918): Difference between revisions

Revision as of 09:17, 25 March 2020

Statements

Navigation menu

Search